Insider · CIK 0001283535
Gary Patou
Files at XENE (Xenon Pharmaceuticals Inc.). First filing Nov 22, 2024, latest Nov 22, 2024.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
XENE: Xenon Pharmaceuticals Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 17Weak | XENEsell Xenon Pharmaceuticals Inc. | $201k 4,891 shares | -19% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 5, 2025 | XENE Xenon Pharmaceuticals Inc. | AGrant or award Share Option (Right to Buy)derivative | +17,012 | $0.00 | $0 | 17,012 | Jun 6, 2025 |
| Jun 5, 2025 | XENE Xenon Pharmaceuticals Inc. | AGrant or award Restricted Share Unitsderivative | +2,645 | $0.00 | $0 | 2,645 | Jun 6, 2025 |
| Nov 22, 2024 | XENE Xenon Pharmaceuticals Inc. | MOption exercise Common Shares | +3,500 | $7.38 | $26k | 27,073 | Nov 22, 2024 |
| Nov 22, 2024 | XENE Xenon Pharmaceuticals Inc. | FTax withholding Common Shares | -649 | $39.80 | $26k | 26,424 | Nov 22, 2024 |
| Nov 22, 2024 | XENE Xenon Pharmaceuticals Inc. | SOpen-market sale Common Shares | -2,851 | $41.11 | $117k | 23,573 | Nov 22, 2024 |
| Nov 22, 2024 | XENE Xenon Pharmaceuticals Inc. | MOption exercise Common Shares | +3,086 | $13.48 | $42k | 26,659 | Nov 22, 2024 |
| Nov 22, 2024 | XENE Xenon Pharmaceuticals Inc. | FTax withholding Common Shares | -1,046 | $39.80 | $42k | 25,613 | Nov 22, 2024 |
| Nov 22, 2024 | XENE Xenon Pharmaceuticals Inc. | SOpen-market sale Common Shares | -2,040 | $41.05 | $84k | 23,573 | Nov 22, 2024 |
| Nov 22, 2024 | XENE Xenon Pharmaceuticals Inc. | MOption exercise Stock Option (Right to Buy)derivative | -3,500 | $0.00 | $0 | 0 | Nov 22, 2024 |
| Nov 22, 2024 | XENE Xenon Pharmaceuticals Inc. | MOption exercise Stock Option (Right to Buy)derivative | -3,086 | $0.00 | $0 | 0 | Nov 22, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.